The most commonly reported adverse events across all treatment arms were gastrointestinal-related, including nausea (17.4 percent [5 mg], 19.2 percent [10 mg], 22.1 percent [15 mg], 17.9 percent [semaglutide]), diarrhea (13.2 percent [5 mg], 16.4 percent [10 mg], 13.8 percent [15 mg], 11.5 percent [semaglutide]) and vomiting (5.7 percent [5 mg], 8.5 percent [10 mg], 9.8 percent [15 mg], 8.3 percent [semaglutide])
doi:10.1007/s13300-011-0002-3 8
This is why someone with normal total LDL cholesterol can still be at high cardiovascular risk if their VLDL and triglycerides are elevatedthe LDL particles are the dangerous small, dense type
CWlR reports grants and other support from the Health Research Board and the Science Foundation Ireland during the conduct of the study
Because of that, many plans choose to exclude weight-management drugs as a way to keep overall costs downeven when those medications are FDA-approved for chronic weight management
2023 [cited 2026 Feb 12]